• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ind-Swift Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7927.0
  • ISIN : INE915B01019
106.67 2 (1.59%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    105.80

  • Today’s High

    110.25

  • Open

    106.00

  • Perv Close

    105.00

  • 52W Low

    68.72

  • 52W High

    186.00

Key Indicators

  • P/E(TTM)

    7.24

  • Mar.Cap (₹Cr.)

    646.62

  • Div & Yield %

    0.00

  • Book Value(₹)

    169.26

  • Debt-Equity Ratio

    1.59

  • AGM Date

    01-Aug-2025

  • EPS

    14.80

  • P/E Ratio

    7.24

Financials Ratios

  • Debt-Equity Ratio

    0.61

  • Mar.Cap (₹Cr.)

    646.62

  • RONW (%)

    19.32

  • ROCE (%)

    20.71

Score Board

  • Equity (₹ in Cr.)

    60.62

  • BV (₹)

    169.30

  • Sales( ₹ in Cr.)

    1,227.32

  • NP (in Cr.)

    137.89

  • NP Var(%)

    147.0

  • Div%

    0.0

  • CPS (₹)

    31.50

  • EPS (₹)

    22.70

  • Traded Value (₹ in Lakhs)

    649.23

  • 52 Week High

    186.00

  • 52 Week Low

    68.72

  • Price BSE

    107.0

  • Price NSE

    107.00

  • Market Capital( in Cr.)

    649.23

  • P/C Ratio

    3.40

  • P/E Ratio

    4.70

  • Price Vs.BV

    22.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,227.32 1,151.96 988.09 856.58 751.84 724.43
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,227.32 1,151.96 988.09 856.58 751.84 724.43
Other Income 431.90 33.28 42.50 23.13 36.02 129.94
Stock Adjustments -37.07 12.34 39.47 2.48 12.44 14.20
Total Income 1,622.15 1,197.58 1,070.06 882.19 800.30 868.57
EXPENDITURE :            
Raw Materials 586.51 629.18 537.62 427.47 391.29 397.43
Power and Fuel Cost 61.43 76.07 58.40 37.31 34.65 37.44
Employee Cost 148.88 132.70 124.62 104.17 100.38 88.94
Other Manufacturing Expenses 42.34 38.53 36.51 28.76 25.73 25.70
Selling and Administration Expenses 77.92 63.98 62.17 78.98 69.66 63.48
Miscellaneous Expenses 23.20 28.40 16.22 1.87 0.62 0.39
Employee Benefit Expenses 148.88 132.70 124.62 104.17 100.38 88.94
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 940.28 968.85 835.54 678.56 622.32 613.39
Operating Profit 681.87 228.73 234.52 203.63 177.98 255.18
Interest 51.10 92.17 95.55 100.22 107.48 92.20
Gross Profit 630.77 136.56 138.97 103.41 70.50 162.98
Depreciation 53.30 57.36 130.97 87.29 90.06 104.05
Profit Before Tax 577.47 79.20 8.00 16.12 -19.56 58.93
Current Tax 169.92 13.36 24.62 11.04 0.41 3.35
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.84 23.36 -10.92 9.48 0.82 16.99
Reported Net Profit 418.39 42.47 -5.71 -4.40 -20.79 38.58
Extraordinary Items 280.50 -13.39 -3.13 0.00 0.07 65.91
Adjusted Net Profit 137.89 55.86 -2.58 -4.40 -20.86 -27.33
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -3.96
P & L Balance brought forward -37.69 -80.16 -74.45 -70.05 -49.26 -83.89
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 380.70 -37.69 -80.16 -74.45 -70.05 -49.26
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 70.81 7.10 -0.95 -0.74 -3.48 7.99
Earnings Per Share(Adj)-Unit Curr 70.81 7.10 -0.95 -0.74 -3.48 7.99
Book Value 156.08 82.26 72.91 71.55 70.15 72.58
Book Value(Adj)-Unit Curr 156.08 82.26 72.91 71.55 70.15 72.58

Shareholding Pattern

  • Promoter Group

    36.77%

  • Public Share Holding

    63.23%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 24,127,507 33.33 24,127,507 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,491,276 3.44 2,491,276 17
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 26,618,783 36.77 26,618,783 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12,299,810 16.99 12,299,810 8
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 554,040 0.77 554,040 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 12,853,850 17.76 12,853,850 11
2] Non Institution
Bodies Corporate 4,183,737 5.78 4,173,937 170
Clearing Members 155,271 0.21 155,271 19
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,541,648 2.13 1,541,648 412
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,023,193 1.41 1,023,193 677
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 14,906,283 20.59 14,906,283 149
Individuals holding nominal share capital up to Rs. 1 lakh 10,507,876 14.52 10,377,526 27,430
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 390,435 0.54 390,435 3
Sub Total 32,914,227 45.47 32,774,077 28,878
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 72,386,860 100.00 72,246,710 28,907

Company Background

Ind-Swift Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ind-Swift Laboratories Ltd
  • BSE Code : 7927.0
  • ISIN : INE915B01019

  • Incorporation Year

    1995

  • Registered Office

    SCO 850 Shivalik Enclave
    NAC Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

    91-0172-5061850/2730920

  • FAX

    91-0172-2730504/2736294

  • Chairman

    N R Munjal

  • Managing Director

    N R Munjal

  • Company Secretary

    Pradeep Verma

  • Auditor

    Avishkar Singhal & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    205/208,
    Anarkali Market,Jhandewalan Extn
    Mumbai - New Delhi - 110055

Ind-Swift Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ind-Swift Labs. 107.10 1,272.63 1,227.32 1.80 20.55
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10